Filters

Anti-CD138 Antibody (FITC)

Anti-CD138 Antibody (FITC) size: 100 tests 412

Supplier ABBEX
Price 412
Size 100 tests
CategoryPrimary Antibodies
TargetCD138 Antibody
ImmunogenSee techfile
ClonalityMonoclonal
Raised inMouse
Reactivity Mouse, Rat, Human
FormFITC
PurificationAffinity purified
ApplicationsWB (for other see techfile or inquire)
Stock availabilityShipped within 5-12 working days
Storage conditions Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C
WarningsThis product is for research use only
Properties FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This abbex Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, abbex FITC is highly sensitive to pH extremes, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by abbex they should be stored frozen at - 24°
ConjugationAnti-FITC Antibody
Gene targetCD138
Short nameAnti-CD138 Antibody (FITC)
Technique Fluorescein, antibodies against human proteins, antibodies for, Antibody
LabelFITC
Alternative nameantibody to-CD138 (Antibody to) (fluorecein)
Alternative techniqueantibodies
Identity 10658
Gene SDC1
Long gene name syndecan 1
Synonyms gene SDC
Synonyms CD138 syndecan SYND1
Synonyms name syndecan proteoglycan 1
Locus 2p24, 1
Discovery year 1991-03-18
GenBank acession AJ551176
Entrez gene record 6382
RefSeq identity NM_001006946
Classification CD molecules Syndecans
Havana BLAST/BLAT OTTHUMG00000090751

Subscribe to our Newsletter